Boston Scientific
FROzEN-AF Trial Results for POLARx Cryoablation System
Pages
2
Time to read
4 mins
Publication
Language
English
Summary
This case study presents the results of the FROzEN-AF trial, evaluating the safety and effectiveness of the Boston Scientific POLARx Cryoablation System for treating recurrent paroxysmal atrial fibrillation. The study highlights procedural characteristics, safety outcomes, and efficacy data, demonstrating high-grade occlusion rates and low recurrence of atrial arrhythmias. Key findings include improved procedural times and significant lesion creation with the 31 mm balloon.
